Skip to main content
Clinical Trials/NCT00563329
NCT00563329
Completed
Not Applicable

Smoking Reduction Intervention for Smokers Not Willing to Quit Smoking: a Randomised Control Trial

Hospital Authority, Hong Kong3 sites in 1 country3,826 target enrollmentOctober 2004

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Smoking Cessation
Sponsor
Hospital Authority, Hong Kong
Enrollment
3826
Locations
3
Primary Endpoint
Adherence Rate to NRT
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

The aims of this study are (1) to examine the effect of smoking reduction intervention (reduction counseling and nicotine replacement therapy, NRT) (a) on smoking cessation and (b) on reducing daily cigarette consumption among smokers not willing to quit smoking but want to reduce smoking, and (2) to examine the effect of adherence intervention in producing a higher (a) adherence rate, (b) reduction rate, and (c) quit rate.

Registry
clinicaltrials.gov
Start Date
October 2004
End Date
July 2006
Last Updated
12 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Hospital Authority, Hong Kong

Eligibility Criteria

Inclusion Criteria

  • Age 18 or above
  • Ethnic Chinese male or female
  • Smokes at least 2 cigarettes per day
  • Have no intention to quit in the near future
  • Intends to reduce smoking in the next 7 days
  • Has no contraindication to NRT

Exclusion Criteria

  • Subjects who are psychologically or physically unable to communicate
  • Children and teenagers (age below 18)
  • Pregnant or intention to become pregnant within the next 6 months
  • Those on regular psychotropic medications and in the presence of any serious health problems that may make them unsuitable for using NRT, such as recent stroke, palpitation, or other life threatening conditions

Outcomes

Primary Outcomes

Adherence Rate to NRT

Time Frame: 4 weeks

quit rate

Time Frame: 6 months

Reduction Rate (reduction of cigarette consumption by at least 50% compared with baseline)

Time Frame: 6 months

Secondary Outcomes

  • Quit rate without validation(1 month)
  • Validated quit rate (by measuring exhaled CO and urinary cotinine level)(6 months)
  • self-reported use of NRT for at least 4 weeks or 8 weeks, without cotinine validation(1 month / 3 month)

Study Sites (3)

Loading locations...

Similar Trials